Interferon

Welcome to the 'Interferon' tag page at Technorati. This page features content from the farthest reaches of the Blogosphere that authors have "tagged" with 'Interferon'.

Latest blogosphere posts tagged “Interferon”

• Helix BioPharma Corp. Completes Enrollment In Its Phase II Trial Of Topical Interferon Alpha-2b In Patients With Ano-Genital Warts

  
  Information on HPV — Authority: 146
  Helix BioPharma Corp. (TSX, FSE: “HBP” / OTCQX: HXBPF) announced that its Phase II trial of Topical Interferon Alpha-2b for the treatment of ano- Genital Warts (AGW) has completed patient enrollment, with the required 120th patient randomized to enter the trial. The double-blind and placebo-controlled Phase II ...
  2 weeks ago

• AASLD: Treating Before Transplant Cuts HCV Recurrence (CME/CE)

  
  Health Fitness & Beauty - health-fitness.marc8.com — Authority: 160
  BOSTON (MedPage Today) -- In patients with advanced liver disease related to hepatitis C, a course of pegylated interferon and ribavirin (Rebetol) before liver transplant may help them avoid recurrence of infection, a researcher said here.
  3 weeks ago

• AASLD: HCV Response Linked Strongly to Gene Variant (CME/CE)

  
  Health Fitness & Beauty - health-fitness.marc8.com — Authority: 160
  BOSTON (MedPage Today) -- Additional analysis has confirmed that a polymorphism in an interferon-related gene is strongly associated with responses to standard treatments for hepatitis C virus (HCV) infection, a researcher said here.
  3 weeks ago

• Extending hepatitis C treatment for liver transplant patients may be beneficial

  
  Thaindian News — Authority: 725
  Washington, Nov 1 (ANI): A study by doctors at Henry Ford Hospital has shown that extending hepatitis C treatment for liver transplant patients results in high rates of clearance of the hepatitis C virus from the blood, as well as a low rate of relapse.“We found that patients who achieved a sustained virological ...
  3 weeks ago

• Zymo Gets $70M for Starting Trial

  
  Xconomy — Authority: 701
  Biotech , clinical trials , Hepatitis C Luke Timmerman wrote: Seattle-based ZymoGenetics (NASDAQ: ZGEN ) will receive a $70 million milestone payment from its partner, Bristol-Myers Squibb, for starting a mid-stage clinical trial of pegylated interferon lambda for hepatitis C, according to a statement . ...
  4 weeks ago

Comments about Interferon